Table 2.
Time post-cardiopulmonary bypass (hours) | ANOVA results (p-values) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Baseline | Group | 0 | 4 | 12 | 24 | 48 | Time | Anti- fibrinolytic |
Interaction | |
IL-2 | 1.6±0.4 | TXA | 0.4±0.2# | 1.2±0.6 | 1.3±0.6 | 0.5±0.3# | 0.4±0.2# | 0.01 | <0.001 | 0.73 |
Aprotinin | 2.5±0.4*# | 5.7±2.6*# | 2.3±0.4*# | 1.7±0.3* | 2.0±0.3* | |||||
IL-6 | 2.1±0.4 | TXA | 43.0±16.4# | 184.4±64.2# | 102.3±18.2# | 60.2±9.6# | 27.3±6.1# | <0.001 | 0.16 | 0.85 |
Aprotinin | 36.3±12.9# | 152.2±24.3# | 85.4±18.7# | 61.7±12.8# | 16.1±2.3*# | |||||
IL-8 | 6.4±0.7 | TXA | 77.9±21.1# | 78.8±18.1# | 36.4±6.7# | 21.3±3.5# | 17.7±4.4# | <0.001 | 0.06 | 0.56 |
Aprotinin | 69.3±28.4# | 89.2±19.4# | 26.0±4.6# | 17.6±2.1# | 10.6±1.5 | |||||
IL-10 | 1.7±0.5 | TXA | 166.1±38.3# | 18.2±6.6# | 9.8±2.6# | 3.7±1.0# | 1.9±0.4 | <0.001 | <0.001 | 0.10 |
Aprotinin | 51.4±10.9*# | 10.3±3.4# | 4.6±0.7# | 3.6±1.0# | 2.5±1.6 | |||||
IL-1β | 0.6±0.3 | TXA | 0.7±0.1 | 0.7±0.1 | 0.5±0.1 | 0.6±0.1 | 1.1±0.4# | 0.03 | <0.001 | 0.07 |
Aprotinin | 0.2±0.1* | 0.6±0.2 | 0.5±0.3 | 1.5±0.9 | 0.1±0.1* | |||||
TNF-α | 3.7±0.5 | TXA | 8.2±1.6# | 9.2±2.0# | 3.7±0.8 | 2.9±0.6 | 3.3±0.7 | <0.001 | 0.10 | 0.29 |
Aprotinin | 9.1±3.7# | 10.4±1.7# | 2.5±0.5 | 1.9±0.3# | 1.4±0.3*# | |||||
INF-γ | 0.5±0.1 | TXA | 0.1±0.1# | 0.1±0.1# | 0.1±0.1# | 0.1±0.1# | 0.1±0.1# | 0.003 | <0.001 | 0.47 |
Aprotinin | 0.6±0.2* | 0.9±0.3*# | 0.5±0.2* | 0.3±0.1 | 0.5±0.1* |
Values represent concentrations in pg/mL and are presented as Mean±SEM.
TXA: tranexamic acid
IL: interleukins; TNF: tumor necrosis factor; INF: interferon; GM-CSF: granulocyte macrophage-colony stimulating factor Sample size: n=37 (TXA: n=15; Aprotinin: n=22)
p<0.05 vs. Baseline.
p<0.05 vs. TXA.